Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

DR Congo Ebola vaccine trials to begin by November: WHO

Trials for three potential vaccines against the Ebola strain that has killed thousands in the Democratic Republic of Congo should begin by October or November, the World Health Organization said Wednesday.

DR Congo Ebola vaccine trials to begin by November: WHO

The World Health Organization (WHO) announced that trials for three potential Ebola vaccines against the strain responsible for the deadliest outbreak in Democratic Republic of Congo (DRC) will begin by October or November. The DRC's 17th Ebola outbreak, declared in May, has resulted in over 3,000 deaths and more than 6,000 infections.

The WHO believes the virus may have begun spreading as early as late January. Currently, there are no approved vaccines or treatments for the Bundibugyo species of Ebola behind the outbreak. Two new vaccines against Bundibugyo virus are currently in safety trials in the U.K. and Canada, while the WHO has recommended a full-scale human trial of Ervebo, a vaccine approved for the more common Zaire strain, to assess its potential cross-protection against Bundibugyo.

Brief written by urgent.news from Medical Xpress's own syndicated text. Machine-written — may contain errors; check the original before relying on it.

Read the original at medicalxpress.com →

More in Health & Medicine

More from Wednesday 2 September →